Table 1 Baseline characteristics of 716 patients included in the study

number (n)

716

430

286

age (years)

55.2 ± 15.2

55.5 ± 15.2

54.8 ± 15.2

no additional risk factor, n (%)

143 (20)

83 (20)

60 (21)

arterial hypertension, n (%)

372 (52)

249 (58)

123 (43)

treated, BP < 140/90 n (%)

125 (17)

77 (18)

48 (17)

treated, BP > 140/90 n (%)

140 (20)

96 (22)

44 (15)

untreated, BP > 140/90 n (%)

107 (15)

76 (18)

31 (11)

hyperlipidemia or statin therapy, n (%)

301 (42)

184 (44)

117 (41)

statin therapy, cholesterol < 5 mmol/l n (%)

99 (14)

61 (14)

38 (13)

statin therapy, cholesterol > 5 mmol/l n (%)

124 (17)

70 (16)

54 (19)

untreated, cholesterol > 5 mmol/l n (%)

78 (11)

53 (12)

25 (9)

MI in family history, n (%)

451 (63)

271 (63)

186 (65)

smoking, n (%)

243 (34)

151 (35)

94 (33)

HbA1c (%)

7.5

7.6

7.5

average number of risk factors

2.9

3.0

2.8

body mass index (kg/m²)

27.1 ± 6.1

28.3 ± 5.8

25.0 ± 4.9

duration of Diabetes (years)

6.5 ± 2.3

6.4 ± 2.2

6.6 ± 2.3

microalbuminuria n (%)

64 (9)

41 (9)

23 (8)

proteinuria n (%)

41 (6)

25 (6)

16 (6)

peripheral neuropathy n (%)

104 (15)

60 (14)

44 (15)

retinopathy n (%)

145 (20)

90 (21)

55 (19)

atrial fibrillation n (%)

95 (13)

61 (14)

24 (12)

insulin only n (%)

105 (15)

62 (15)

43 (15)

insulin + oral agent n (%)

109 (15)

70 (16)

39 (14)

oral agent only n (%)

502 (70)

298 (69)

204 (71)